Record 7335   View: Standard Glossary  HistCite Guide
Author(s): BOND JA; WYLLIE FS; WYNFORDTHOMAS D
Title: ESCAPE FROM SENESCENCE IN HUMAN-DIPLOID FIBROBLASTS INDUCED DIRECTLY BY MUTANT P53
Source: ONCOGENE 9 (7): 1885-1889
Date: 1994 JUL
Document Type: Journal : Article
DOI:  
Language: English
Comment:  
Address: UNIV WALES COLL MED,DEPT PATHOL,CANC RES CAMPAIGN,THYROID TUMOUR BIOL GRP,CARDIFF CF4 4XN,S GLAM,WALES.
Reprint:  
E-mail:  
Author Keywords:  
KeyWords Plus: EPITHELIAL-CELLS; P53-DEFICIENT MICE; TUMOR SUPPRESSION; CANCER SYNDROME; IMMORTALIZATION; TRANSFORMATION; ABNORMALITIES; MECHANISMS; RB
Abstract: Cellular senescence is thought to be a key restraint on the progression of human tumours, escape from which involves loss of function of tumour suppressor genes. The number and nature of the genes involved however is uncertain, in particular the role of p53 mutation, which is commonly correlated with tumour progression. To address this question, we used the novel approach of directly assessing the effect of mutant p53 on 'pre-aged' human diploid fibroblasts (HDF), thereby avoiding the uncertainty of additional cooperating events, inherent in transgenic models. HDF were passaged till near-senescent and then infected with an amphotropic retroviral vector encoding an ala143 human mutant p53. The results show conclusively that p53 mutation alone is sufficient to extend the proliferative lifespan of normal fibroblasts by approximately 17 population doublings, but has no phenotypic effect on 'young' fibroblasts. We conclude that a key tumour-limiting function of wild-type p53 is to mediate growth arrest after a given number of cell divisions, in agreement with data implicating a p53-regulated gene, WAF-1/sdi-1, in cellular senescence. This may be reconciled with its 'guardian of the genome' role, if telomere erosion, a key change in senescence, is perceived by the cell as a form of DNA 'damage'.
Cited References:
BISCHOFF FZ, 1990, CANCER RES, V50, P7979
BISCHOFF FZ, 1991, ONCOGENE, V6, P183
BURNS JS, 1992, MOL CARCINOGEN, V6, P129
CHEN PL, 1990, SCIENCE, V250, P1576
COUNTER CM, 1992, EMBO J, V11, P1921
ELDEIRY WS, 1993, CELL, V75, P817
HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528
HARLEY CB, 1990, NATURE, V345, P458
HARVEY M, 1993, ONCOGENE, V8, P2457
HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
LANE DP, 1992, NATURE, V358, P15
NODA A, IN PRESS EXP CELL RE
SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1
SHAY JW, 1991, EXP CELL RES, V196, P33
SHAY JW, 1993, ONCOGENE, V8, P1407
TSUKADA T, 1993, ONCOGENE, V8, P3313
WYLLIE FS, 1991, MOL CELL ENDOCRINOL, V76, P13
WYLLIE FS, 1993, MOL CARCINOGEN, V7, P83